Dr. Usman's Cardiology Notes

  Cardiac Resynchronization Therapy (CRT): Indications Introduction Cardiac Resynchronization Therapy (CRT) is an established device-based treatment for patients with heart failure and electrical dyssynchrony, particularly in the setting of prolonged QRS duration. It improves symptoms, reduces hospitalizations, and decreases mortality in appropriately selected patients. --- Pathophysiologic Basis Ventricular dyssynchrony (especially with LBBB) → inefficient LV contraction Reduced stroke volume and increased mitral regurgitation CRT restores coordinated ventricular contraction → improves cardiac output --- Core Indications (Guideline-Based) Strong Indications (Class I) CRT is recommended in patients with: Symptomatic heart failure (NYHA class II–IV despite optimal medical therapy) LVEF ≤35% Sinus rhythm Left bundle branch block (LBBB) morphology QRS duration ≥150 ms Key takeaway: 👉 Best responders = LBBB + wide QRS ≥150 ms --- Moderate Indications (Class IIa) CRT should be consider...

Cerebral T Waves on ECG Introduction Cerebral T waves are deep, symmetric T-wave inversions on electrocardiography (ECG) associated with acute central nervous system (CNS) injury. These ECG changes are most commonly seen in intracranial hemorrhage, particularly subarachnoid hemorrhage (SAH), but may occur in other acute neurologic catastrophes. Recognition of cerebral T waves is important because they can mimic myocardial ischemia, potentially leading to misdiagnosis and inappropriate cardiac interventions. --- Definition Cerebral T waves are characterized by: Deep (≥5 mm) Symmetric Broad-based T-wave inversions Usually seen in the precordial leads (V2–V6) and sometimes in limb leads. These changes occur due to autonomic nervous system dysregulation and catecholamine surge triggered by acute brain injury. --- ECG Characteristics Typical ECG findings include: 1. Deep Symmetric T-Wave Inversions Most prominent in anterior and lateral leads Often giant T wave inversions 2. QT Interval Pro...

  E-point septal separation (EPSS) E-point septal separation (EPSS) is a simple M-mode echocardiographic measurement used to assess left ventricular (LV) systolic function. 🔹 Definition ▪︎ EPSS = distance (in mm) between: ○ The E-point (maximal early diastolic opening of the anterior mitral valve leaflet) ○ And the interventricular septum ▪︎ Measured in parasternal long-axis view (PLAX) using M-mode. 🔹 Normal vs Abnormal ▪︎ Normal: ≤ 5–7 mm ▪︎ Mildly increased: 7–10 mm ▪︎ Severely increased: > 10 mm 🔹 Clinical Significance 👉 EPSS is inversely related to LV ejection fraction (EF) ▪︎ Small EPSS → normal EF ▪︎ Large EPSS → reduced EF EPSS – Key Equation (Clinical Estimation of EF) 👉 LVEF (%) ≈ 75.5 − (2.5 × EPSS in mm) 🔹 Example EPSS = 10 mm → EF ≈ 75.5 − (2.5 × 10) → EF ≈ 50% EPSS on Echocardiography E-Point Septal Separation --- Definition EPSS (E-Point Septal Separation) is the minimal distance between the anterior mitral valve leaflet (E-point) and the interventricular se...

  Echo Evaluation of PS and PR Pulmonary valve disease is commonly encountered in congenital and adult cardiology practice. Echocardiography remains the primary tool for diagnosis, severity assessment, and follow-up of Pulmonary Stenosis (PS) and Pulmonary Regurgitation (PR). A systematic echocardiographic approach helps determine valve morphology, hemodynamic severity, and the impact on right ventricular function. --- INTRODUCTION Pulmonary valve pathology may occur as isolated congenital disease, after surgical repair of congenital heart defects, or secondary to pulmonary hypertension and endocarditis. Echocardiography provides comprehensive evaluation through: • Valve morphology • Doppler hemodynamics • Right ventricular size and function • Associated congenital abnormalities Both PS and PR primarily affect the right heart, making careful right-sided assessment essential. --- ECHOCARDIOGRAPHIC VIEWS FOR PULMONARY VALVE The pulmonary valve can be visualized in several standard ec...

  Pharmacologic Therapy for Acute Aortic Dissection --- Introduction Acute Aortic Dissection is a life-threatening cardiovascular emergency caused by a tear in the intimal layer of the aorta, allowing blood to enter the medial layer and create a false lumen. Rapid reduction of aortic wall stress is the cornerstone of initial management. Pharmacologic therapy aims to reduce aortic shear stress, control blood pressure, and limit propagation of the dissection until definitive management such as surgery or endovascular repair is performed. Guideline-directed therapy is primarily based on recommendations from the American Heart Association and European Society of Cardiology. --- Hemodynamic Goals The primary goal is to decrease aortic wall stress (dP/dt) by controlling both heart rate and blood pressure. Target parameters: • Heart rate: < 60 beats/min • Systolic BP: 100–120 mmHg (if tolerated) • Adequate organ perfusion must be maintained Reducing heart rate before aggressive blood p...

 PRIMARY MITRAL REGURGITATION MANAGEMENT Clinical Guide for Physicians --- WHAT IS PRIMARY MITRAL REGURGITATION? Primary Mitral Regurgitation (MR) occurs when the mitral valve apparatus itself is structurally abnormal, leading to backflow of blood from the left ventricle to the left atrium during systole. Common causes include: • Mitral valve prolapse • Degenerative mitral valve disease • Flail leaflet due to chordae rupture • Rheumatic disease • Infective endocarditis • Congenital cleft mitral valve The severity of regurgitation determines management strategy. --- CLASSIFICATION Primary MR is classified based on severity and symptoms. Mild MR Small regurgitant jet with no hemodynamic impact. Moderate MR Larger jet but without significant LV remodeling. Severe MR Characterized by: • Regurgitant volume ≥ 60 ml • Regurgitant fraction ≥ 50% • Effective regurgitant orifice area (EROA) ≥ 0.40 cm² --- CLINICAL PRESENTATION Patients may present with: • Dyspnea on exertion • Fatigue • Palp...

 NSTEMI Timing and Management --- Introduction Non–ST Elevation Myocardial Infarction (NSTEMI) is a common form of Acute Coronary Syndrome (ACS) characterized by myocardial necrosis without persistent ST-segment elevation on ECG. It results from partial or transient occlusion of a coronary artery and requires rapid risk stratification and timely management to prevent progression to larger infarction or death. Early recognition and appropriate timing of invasive management are critical components of modern NSTEMI care. --- Pathophysiology NSTEMI usually occurs due to rupture or erosion of an atherosclerotic plaque followed by platelet aggregation and thrombus formation. Unlike STEMI, the occlusion is often incomplete or intermittent, leading to subendocardial ischemia rather than full-thickness myocardial infarction. Key mechanisms include: • Plaque rupture with non-occlusive thrombus • Severe coronary artery stenosis • Coronary vasospasm • Supply–demand mismatch in vulnerable myoca...